{
    "id": 22720,
    "cites": 18,
    "cited_by": 0,
    "reference": [
        "Acemoglu, D., Finkelstein, A., and Notowidigdo, M. J. (2013). Income and health spending: Evidence from oil price shocks. Review of Economics and Statistics, 95(4):1079\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1095.",
        "Acemoglu, D. and Linn, J. (2004). Market size in innovation: Theory and evidence from the pharmaceutical industry. The Quarterly journal of economics, 119(3):1049\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1090.",
        "Azoulay, P., Zivin, J. S. G., Li, D., and Sampat, B. N. (2015). Public r&amp;d investments and private-sector patenting: evidence from nih funding rules. Technical report, National Bureau of Economic Research.",
        "Blume-Kohout, M. E. and Sood, N. (2013). Market size and innovation: E\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acects of medicare part d on pharmaceutical research and development. Journal of public economics, 97:327\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 336.",
        "Blundell, R., Gri\u00c3\u00af\u00c2\u00ac\u00c6\u0092th, R., and Windmeijer, F. (2002). Individual e\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acects and dynamics in count data models. Journal of Econometrics, 108(1):113\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c131.",
        "Budish, E., Roin, B. N., and Williams, H. (2015). Do firms underinvest in long-term research? evidence from cancer clinical trials. The American economic review, 105(7):2044\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2085.",
        "Danzon, P. M. (2011). The economics of the biopharmaceutical industry. In Glied and Smith (eds), The Oxford Handbook of Health Economics (Oxford, 2011), pages 520\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c554.",
        "DiMasi, J. A., Hansen, R. W., and Grabowski, H. G. (2003). The price of innovation: new estimates of drug development costs. Journal of health economics, 22(2):151\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c185.",
        "DiMasi, J. A., Hansen, R. W., Grabowski, H. G., and Lasagna, L. (1991). Cost of innovation in the pharmaceutical industry. Journal of health economics, 10(2):107\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c142.",
        "Dubois, P., de Mouzon, O., Scott-Morton, F., and Seabright, P. (2015). Market size and pharmaceutical innovation. The RAND Journal of Economics, 46(4):844\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c871.",
        "Duggan, M. and Morton, F. S. (2010). The e\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acect of medicare part d on pharmaceutical prices and utilization. The American Economic Review, 100(1):590\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c607.",
        "Finkelstein, A. (2004). Static and dynamic e\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acects of health policy: Evidence from the vaccine industry. The Quarterly Journal of Economics, 119(2):527\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c564.",
        "Hall, R. E. and Jones, C. I. (2007). The value of life and the rise in health spending. Technology, 39.",
        "Koijen, R. S., Philipson, T. J., and Uhlig, H. (2016). Financial health economics. Econometrica, 84(1):195\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c242.",
        "Kola, I. and Landis, J. (2004). Can the pharmaceutical industry reduce attrition rates? Nature reviews Drug discovery, 3(8):711\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c716.",
        "Scannell, J. W., Blanckley, A., Boldon, H., and Warrington, B. (2012). Diagnosing the decline in pharmaceutical r&amp;d e\u00c3\u00af\u00c2\u00ac\u00c6\u0092ciency. Nature reviews Drug discovery, 11(3):191\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c200.",
        "Scherer, F. M. (2001). The link between gross profitability and pharmaceutical r&amp;d spending. Health A\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acairs, 20(5):216\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c220.",
        "Toole, A. A. (2012). The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry. Research Policy, 41(1):1\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c12."
    ]
}